|
Big News From Stock Marketing Inc.!! LGTT "LocatePC Launches Commercial Campaign With Georgia State, Georgia Tech and University of Georgia":: Sign Up Today!!
(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (PINKSHEETS: LGTT) LIGATT Security International, Inc., (OTCBB: INOL) InoLife Technologies, Inc., (OTCBB: CNOZ) Cono Italiano, Inc., (PINKSHEETS: AAVG) AvStar Aviation Group, Inc., (OTCBB: IPMN) Imperial Petroleum, Inc., (PINKSHEETS: CEHC) Cephas Holding Corp.
www.StockMarketingInc.com
For More Information email us!! Steve@StockMarketingInc.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(PINKSHEETS: LGTT - LIGATT Security International, Inc.)
LATEST NEWS!! LocatePC Launches Commercial Campaign With Georgia State, Georgia Tech and University of Georgia
ATLANTA, Sep 2, 2010 -- LIGATT Security International, (Pink Sheets: LGTT) a cyber security company, today announced that the company's signature product, LocatePC, official commercial launch will be airing tonight at Georgia State University's inaugural game. LocatePC's commercial will also be airing at Georgia Tech and University of Georgia this weekend.
The Georgia State University Panthers will be playing their inaugural game at the Georgia Dome -- home of the Atlanta Falcons -- versus the Shorter University Hawks tonight at 7:30 p.m. With this being Georgia State University's first game in history, a number of students, faculty and alumni are expected to be in attendance. In addition, the University anticipates attendance of city officials, such as Governor Sonny Perdue. University of Georgia is expecting over 100,000 attendees at this Saturday's opening game, along with Georgia Tech, whose expected attendance is 60,000.
"We are looking to work with additional major universities every month," comments Gregory Evans, President and CEO of LIGATT Security International. "The amount of exposure advertising at these games is phenomenal. Over 180,000 people will see our new commercial. With our products being sold on or around their campuses, LocatePC is sure to be a success. We are excited and believe this marketing campaign will take LocatePC to another platform." LocatePC will enable a person to track their stolen computer anywhere in the world. LocatePC runs unobtrusively on a computer, with no icons and pop-ups. This invisible software is designed to work with the majority of Windows operating systems, including Windows 7, Windows Vista, XP, and Windows Live.
LIGATT Security's advertisements include banners and commercials geared toward college students. LocatePC will be available for purchase at the school's campus bookstores.
About LIGATT Security International LSI is the nation's premier hi-tech security company and recognized as a leader in computer security and cyber-crime investigation. It is a publicly traded company whose mission is to be the nation's leading provider of hi-tech crime investigations, by protecting their clients against Black Hat Hacking one CPU at a time.
For additional information on LocatePC visit www.ligattsecurity.com/solutions/locate-pc. For more information on additional products and services visit www.ligatt.com.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(OTCBB: INOL - InoLife Technologies, Inc.)
LATEST NEWS!! InoLife Technologies, Inc. to Market a Plavix Metabolizing Test to the Medical Industry
DNA Test Enables Physicians to Predict Medication Response in Patients for Effective Treatment
RALEIGH, NC, Sep 01, 2010 InoLife Technologies, Inc. (OTCBB: INOL), a service based healthcare products development, integration and marketing Company, announced today it will provide and market a proprietary metabolizing test to physicians and practitioners to identify how a patient's genetic makeup may affect the body's response to Plavix (colpidogrel).The test will only be made available to physicians.
The Food and Drug Administration recently announced that Plavix must now carry a so-called "black box" warning label after a landmark study revealed that patients who were "non-responders" as a result of a genetic variation were "3.58 times more likely to have a fatal stroke or myocardial infarction." Plavix, an $8-billion-a-year drug and considered to be the second best selling drug in the world, reduces the risk of heart attack, stroke, and cardiovascular death in patients with cardiovascular disease by making platelets less likely to form blood clots.Plavix does not have its anti-platelet effects until it is metabolized into its active form by the liver enzyme, CYP2C19.
"We determined that there are three critical problems that can lead to a level of non-response to Plavix," said Dr. Frederic J. Vagnini, M.D., FACS, a board certified cardiovascular surgeon who, after more than 20 years of performing heart surgery, has turned his clinical practice to the prevention of heart and related diseases. "First, in anyone an abnormality may be present within a gene abbreviated as CYP2C19 (and other variants) which significantly increases the risk of stroke or death due to clotting failure. Second, there are different variants or mutations between ethnic groups; some studies have indicated that one in three Caucasians and 40% of Asian of African-American populations have this abnormality.
"Among clinicians there have been discussions centering on differing dosing approaches. Perhaps the most important result of InoLife's DNA test is that each patient will be able to have an individually tailored course of treatment since some require longer periods on it," Vagnini stated.
InoLife Technologies feels that this is an important test for those who take Plavix or who may need to take Plavix in the future. The Company is very pleased that by addressing the black box warning, those who can be helped by this medication will be.
InoLife's Plavix Metabolizing Test is only available to physicians and medical professionals. It is not available for home use. Please ask your physician.
(Plavix is a trademark of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.) About InoLife Technologies, IncPositioned for growth and success in a burgeoning market, InoLife Technologies,www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end-users. The Company's mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions for both humans and companion animals.The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.
The principal customers of InoLife's products and services are healthcare providers, physicians, practitioners, hospitals, outpatient facilities and veterinarians. Emphasis is being placed on individuals with a direct need for the DNA testing solutions. InoLife will be marketing and distributing its proprietary products to a wide variety of customers through e-commerce, direct sales, healthcare providers, distributors and retail sellers including pharmacies, specialty retailers and drugstores.
----------------------------------------------------------------------------------------------------------------------------------------------------------------
(OTCBB: CNOZ - Cono Italiano, Inc.)
LATEST NEWS!! Cono Italiano and AOL Conduct Pizza Cono Taste Test
RED BANK, NJ, Sep 02, 2010 -- Cono Italiano, Inc. (OTCBB: CNOZ), the exclusive license holder of the North American Distribution and Manufacturing rights for "pizza cono" a cone-shaped pizza and "on-the-go" food product, recently performed a "pizza cono" taste test for the food editors at AOL, known for their popular online food destinations like Slash Food and Kitchen Daily.
At the request of New York-based AOL Inc., Cono Italiano paid a visit to the AOL office on August 21 to perform a comprehensive "pizza cono" food tasting. The demonstration included a multitude of "pizza cono" varieties including: Traditional, Pizza, Meatball, Taco and a breakfast cone made of egg whites and cheese. The cones were prepared in a microwave using Cono Italiano's patented microwaveable sleeve, a process that maintains the integrity of the cone and keeps the dough crisp and crunchy.
"Given the popularity of Bagel Bites and Hot Pockets in the frozen food section, I could see Pizza Cones being the next big thing, especially with kids," said Sara De Heer, editor with Slash Food and Kitchen Daily.
"The taste test was a huge success and really showed the versatility of the cone with its different and delicious varieties while maintaining the drip free concept," said Mitchell Brown, CEO of Cono Italiano, Inc.
About Cono Italiano, Inc. Cono Italiano, Inc. owns the North American distribution and manufacturing rights for Pizza Cono. This Pizza Cone is designed to be a drip free, spill free cone-shaped pizza made of proprietary dough and filled with freshly selected ingredients. The Company intends that the Pizza Cone will be distributed through the fast food market. The Pizza Cone will be distributed to quick-service restaurants (QSR), takeaways, and leisure locations. These establishments include typical fast food chains, supermarkets, convenience stores, entertainment facilities and sports arenas. For more information, please visit: www.conoitaliano.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(PINKSHEETS: AAVG - AvStar Aviation Group, Inc.)
LATEST NEWS!! AvStar Aviation Plans Substantial Increase in Fleet, Routes, Services, and Amenities
HOUSTON, TX, Sep 01, 2010 -- AvStar Aviation Group Inc. (PINKSHEETS: AAVG) is proud to announce that our Limited company is actively working with several potential lenders to secure the needed funding to refurbish our fleet of aircraft. The completion of this refurbishment will provide additional capacity on our existing routes. The refurbishment will also allow AvStar to expand with new routes for the busy winter travel period to the Bahamas. The West Palm Beach to Abaco Island in the northern Bahamas will be our first new route for the 2010-2011 winter season. Previously engaged with routes to only five locations in the Bahamas and one in Florida, AvStar will now have the equipment and capacity to offer both more destinations and more opportunities for commercial passenger and freight demand. This expansion is expected to increase revenues as well as enhance brand awareness for both potential passengers and potential shareholders alike.
Clayton Gamber, CEO, states, "This is an exciting time for AvStar Aviation. As the company grows and expands it will be necessary to keep our fleet modern, comfortable, accessible, and -- most importantly -- safe for our passengers. Adding more routes, and increasing aircraft size while promoting the luxuries of newer aircraft are some of the small ways we intend to grow our brand in the months to come. More exciting still are our continuing acquisition plans, the newly appointed expert staff members, and the vertical integration of our Services and Limited companies also providing third party services gives us a clear edge in several markets." The year 2010 has brought about many positive changes for the company as revenues grow and the budget for advertising increases. Potential shareholders can view the recent CEO letter to shareholders for more details.
About AvStar Aviation: AvStar Aviation Group, Inc. ("AvStar") has a main focus on acquiring, consolidating, and growing businesses in the aviation industry. Also, the company is focusing on acquiring and/or developing companies that provide products and services for the general aviation industry. Please visit www.avstarinc.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(OTCBB: IPMN - Imperial Petroleum, Inc.)
LATEST NEWS!! Imperial Biofuels Subsidiary Clears Milestone
EVANSVILLE, Ind., Sep 01, 2010 -- Imperial Petroleum, Inc. (OTCBB: IPMN) announced that its wholly-owned subsidiary, e-biofuels, LLC, a Middletown, Indiana biodiesel producer, cleared a milestone in its development. After becoming part of Imperial and as the result of negotiating a series of feedstock purchase agreements and biodiesel off-take sales contracts, e-biofuels generated revenues of approximately $3.5 million in the month of July 2010 alone on fuel sales of about 1.2 million gallons and as a result the subsidiary expects to be highly profitable going forward. Fuel sales for August 2010 are approximately 1.4 million gallons with revenues of just over $4.0 million for the month.
"Expanding the plant throughput to its current capacity was one of our early goals for e-biofuels and a great deal of credit goes to the management of e-biofuels for their efforts and achievements thus far. August sales to date are on pace to exceed the July results," commented Jeffrey T. Wilson, President of Imperial. "As a result of the mandates under the Renewable Fuels programs, e-biofuels has been in a unique position to take advantage of its certification as an advanced biofuels producer to rapidly increase its market presence. Our products are sold to some of the largest retail outlets and truck stop owners in the United States. Upon the closing of our financing for the Company, we expect to proceed quickly to expand the biodiesel production capacity to 25 MMGPY; convert the plant over to our more-efficient process technology and add bio-jet fuel capabilities. Our goal is to add slow pyrolysis equipment into the facility over the next year to produce both electricity for re-sale to the power grid and bio-oil for inclusion in our renewable boiler fuel and renewable heating oil products." Imperial is an energy company headquartered in Evansville, Indiana.
------------------------------------------------------------------------------------------------------------------------------------------------------------
(PINKSHEETS: CEHC - Cephas Holding Corp.)
LATEST NEWS!! Cephas Provides Corporate Update
PHOENIX, AZ, Sep 02, 2010 -- Cephas Holding Corp (PINKSHEETS: CEHC) today issued an update regarding corporate activities. SEC Filings. The Company has received its audited financial statements from Silberstein, Unger with the consent to file the 2009 10-K. Management is completing its review of the narrative portion and intends to file the annual report shortly. Additionally, the company expects to file the remaining Form 10-Qs to become current in its reporting. Upon submission of the outstanding filings, Cephas will once again become eligible for the OTCBB and will make application through a market maker.
iPhone/iPad. Cephas has completed the development of the Fedor Emelinenko signature application. Release of Fedor Mobile is expected within 30 days. Cephas has signed a three year contract with UFC and Pride superstar Wanderlai Silva to develop signature iPhone applications. Cephas is actively negotiating with other MMA brands and stars for the iPhone and iPad categories. The Company is finalizing an update for its MMAUnderboss application. The company believes that it can be a leader in MMA applications for the iPhone platform.
Cephas deems its "Metal News" application a successful test of the advertiser supported model for iPhone application. The Company will look to develop more advertiser driven apps in the future.
Other Activity. The company's investment in a modeling venture continues to show great promise. The company intends to provide further information on its agency investment after the filing of the company's 10-K. Finally, Cephas has also settled a shareholder lawsuit.
------------------------------------------------------------------------------------------------------------------------------------------------------------
About StockMarketingInc.com
StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
((Comments on this story may be sent to info@m2.com))
(c) 2010 M2 COMMUNICATIONS
[ Back To Homepage ]
|